Consumers Financial Corp. (CNSF)

[jackrussell]

Here's the skinny, folks.

I always like to go right to the sources instead of relying on other traders' DD in the pinkies. No offense, folks. I'm sure you're all very fine, upstanding citizens who posess a burning desire to help me make money. In any case, I now feel more comfortable about my position in CFCJ having nailed down the following connection:

Consumers Financial Corporation Looks to Enter Billion Dollar Medical Application Industry With Patented Technology

CEDARHURST, N.Y., Jan 12, 2007 (PrimeNewswire via COMTEX) -- As previously reported in July of 2006, Consumers Financial Corporation (Pink Sheets:CFCJ) and Knowledge Market, Inc. entered into a mutual agreement whereby Knowledge Market, Inc. identifies R&D projects from MIT, Harvard, Lawrence Livermore National Laboratory, University of Florida,Cambridge University (UK), Stanford University, NEC, NASA, University of California, Los Alamos National Laboratory and presents to Consumers Financial Corporation. Consumers Financial Corporation working in tangent with Knowledge Market has highlighted the first project.

A brief description of the technology is given below.

Optical Probe For Medical Applications

Researchers have developed a new, minimally invasive diagnostic Optical Probe that can instantly identify abnormal tissue, including cancerous tissue. The Optical Probe removes no tissue and is expected to achieve accuracy levels comparable to surgical biopsies in detecting cancerous cells. The optical probe assembly consists of control unit containing a laser unit, detectors, and control circuitry. Optical fibers emerge from the unit and these optical fibers transmit light to and from the tissue through a needle probe. This needle probe is smaller than the needle used in routine blood tests. The optical probe assembly also includes a reference optical fiber as part of the fiber optics, which improves the accuracy of the unit by accounting for optical source variations and changes in the fiber optic transmission efficiencies. The successful deployment of this optical probe could provide a new, minimally invasive diagnostic tool that could instantly detect cancerous tissue, which would result in a reduction in the amount of unnecessary biopsies and surgeries. Medical professionals estimate this would have the potential to save the U.S. healthcare system over $2 billion annually. This device is protected by one U.S. Patent.
________________________________________________________________

AND:

_________________________________________________________________

LAWRENCE LIVERMORE NATIONAL LABORATORY SEEKS LICENSEE TO PRODUCE A OPTICAL PROBE FOR MEDICAL APPLICATIONS
Announcement: Lawrence Livermore National Laboratory (LLNL), operated by the University of California under contract with the U.S. Department of Energy (DOE), wants to license its technology pertaining to Medical Optical Probes.

Researchers at LLNL have developed a new, minimally invasive diagnostic Optical Probe that can instantly identify abnormal tissue, including cancerous tissue. The Optical Probe removes no tissue and is expected to achieve accuracy levels comparable to surgical biopsies in detecting cancerous cells.

The optical probe assembly consists of control unit containing a laser unit, detectors, and control circuitry. Optical fibers emerge from the unit and these optical fibers transmit light to and from the tissue thru a needle probe. This needle probe is smaller than the needle used in routine blood tests. The optical probe assembly also includes a reference optical fiber as part of the fiber optics, which improves the accuracy of the unit by accounting for optical source variations and changes in the fiber optic transmission efficiencies.

The successful deployment of this optical probe could provide new, minimally invasive diagnostic tool that could instantly detect cancerous tissue, which would result in a reduction in the amount of unnecessary biopsies and surgeries. Medical professionals estimate this would have the potential to save the U.S. healthcare system over $2 billion annually.

This device is protected by one U.S. Patent (6,647,285).

_________________________________________________________________

AND THE PATENT:

________________________________________________________________

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPT...